Shifeng Xu

830 citations
22 papers · 456 indexed · h-index 12
Topics
Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers)Cancer-related molecular mechanisms research (4 papers)Cancer, Hypoxia, and Metabolism (3 papers)
Partner nations
ChinaSwedenUnited States

In The Last Decade

Shifeng Xu

22 papers receiving 449 citations

Peers

Shifeng Xu
Comparison fields: 5 of 63
  • Molecular Biology 239
  • Cancer Research 177
  • Oncology 143
  • Pulmonary and Respiratory Medicine 109
  • Surgery 61
Replace Meijin Huang with:
Meijin Huang China
Teruhide Ishigame Japan
Lingzhi Hong United States
Xianshuo Cheng China
Songming Ding China
Tahir Qayyum United Kingdom
Mingxu Da China
Qirong Geng China
Yao-fei Pei China
Alfredo Pastorelli Italy
Shifeng Xu relative to Meijin Huang China Meijin Huang's profile →
Citations per field
00.5×1.5×
Meijin Huang · 1×
Citations per year

Countries citing papers authored by Shifeng Xu

Since Specialization
Citations

This map shows the geographic impact of Shifeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shifeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shifeng Xu more than expected).

Fields of papers citing papers by Shifeng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shifeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shifeng Xu. The network helps show where Shifeng Xu may publish in the future.

Co-authorship network of co-authors of Shifeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Shifeng Xu. A scholar is included among the top collaborators of Shifeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shifeng Xu. Shifeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 1
5 12
6 20
7 8
8 17
9 29
10 16
11 20
12 14
13 10
14 214
15 1
16 15
17 26
18 12
19 31
20
[Refined mapping of heterozygosity loss on chromosome 5p15 in sporadic colorectal cancer].
1

About Shifeng Xu

Shifeng Xu is a scholar working on Cancer Research, Applied Microbiology and Biotechnology and Oncology, having authored 22 papers that have together received 456 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (177 citations), Oncology (143 citations) and Hepatology (29 citations). Shifeng Xu has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include Yuanwen Zheng, Guohe Song, Lin Zhong, Yupeng Wang, Chao Xiao, Xing Sun, Chongzhi Zhou, Xiaoliang Wang, Tao Jiang and Tao Zhang. Their work appears in journals such as Journal of Clinical Oncology, Journal of Clinical Pathology and Journal of Cellular Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026